← Eichor
Condition: Romiplostim N01 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Romiplostim N01

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07043894Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Th
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07206823Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gast
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT07586813Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06686927Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
Phase 2 · 1 location(s) · Anhui Provincial Hospital · NCT06693791A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06658834Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06613880Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07063225Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gyne
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT07586826Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Le
Phase 2 · 1 location(s) · Anhui Provincial Hospital · NCT06898983Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07321626Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Throm
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06992128A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleuk
Phase 3 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06759636
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.